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Introduction
Rabies is a ubiquitous fatal disease and its large wild life 
reservoir may precipitate a flare-up whenever stringent 
control is relaxed. It remains a serious public health chal-
lenge in the developing world. It is estimated that up to 
40–60,000 cases of  human rabies occur annually, mostly 
in rural areas of  Africa and Asia, and with a particularly 
high incidence in young children (under the age of  15 
years). Although Tunisia has implemented a national pro-
gram against rabies since 1982, we are still recording one 
or two cases every year; in these cases, the victims gen-
erally did not consult after a dog bite and did not receive 
prophylaxis.
We report in this article the case of  an eleven year old 
child, who received post exposure prophylaxis and unfor-
tunately developed fatal rabies.
Case report
An eleven year old boy was brought to the emergency de-
partment for fever, vomiting and acute speech troubles, 
he had no remarkable medical history and his develop-
mental milestones were normal. On physical examina-
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tion, he was febrile at 38.5°c, he had no signs of  menin-
geal irritation; he had strabismus, dysarthria, tremor, deep 
tendon reflexes were very weak. Noteworthy,  he had an 
intense thirst and desire to drink, but he  was unable to 
swallow because of  pharyngeal spasms.
Cerebral CT scan was performed and did not show any 
abnormalities. Blood count revealed neutrophilic leuco-
cytosis; normal C reactive protein and normal electrolytes 
levels were found.
On further questioning, his mother revealed a history of  
a stray dog bite two weeks prior. The patient was bitten in 
his face (lips and the inner cheek); wounds were sutured 
and he received 12 hours later, a maximum dose of  equine 
rabies immunoglobulin (ERIG) 40UI/kg (Pasteur) into 
the wound and the rest intramuscularly into the deltoid 
region on day 0 after wound cleaning and four doses of  
rabies vaccine ( purified chicken embryo rabies vaccine 
PCEC, Rabipur, Novartis vaccines) intramuscularly into 
the deltoid region on days: 0, 3, 7 and 14 following WHO 
guidelines (ESSEN regimen+ERIG).
Four hours after admission, he became furious, and de-
veloped hyper-salivation. His condition deteriorated and 
he succumbed to death although he was intubated and 
ventilated. Post-mortem cerebrospinal fluid showed a 
pleocytosis with  400 leucocytes (80% lymphocytes).
On autopsy, biopsies of  cerebral cortex, cerebellum, hip-
pocampus and medulla were positive for rabies antigen 
on fluorescent antibody technique.
Discussion
Rabies is fatal encephalitis of  viral origin in humans and 
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some other mammals. It is estimated that up to 40–60,000 
cases of  human rabies occur annually, and a dog bite is 
the cause of  over 98%.1 It is still a major health problem 
in the developing world and has medical and economic 
implications: nearly 4 million people receive post-expo-
sure prophylaxis (PEP) annually.
In Tunisia, rabies PEP (RPEP; vaccine+immunoglobu-
lin) is free of  charge and is included in the national ra-
bies control programme. There are specialised centres in 
many regions of  our country for RPEP.
One or two cases of  fatal human rabies have been rec-
ognised per year in Tunisia; in these cases, the victims 
generally did not consult after a dog bite and did not re-
ceive prophylaxis.
True prophylaxis failures are rare and the most cases of  
RPEP management failure are due to errors of  manage-
ment.
Like the Lyssa virus, rabies virus is a neurotropic virus, 
clinical manifestations begin at least five to six days after 
the virus has reached the central nervous system4.
We recognize two forms of  human rabies, the well known 
classical form or encephalitic (furious) that occurs in 70% 
of  the cases and the paralytic (dumb) rabies in 30% of  
clinical presentations.
Clinical features of  the disease can be devided into five 
stages: incubation period,prodrome phase, the acute neu-
rologic phase and coma then death5. Incubation phase 
usually lasts between 20 to 60 days, shorter and longer 
periods has been reported (from  few days to 19 years). 
The post exposure prophylaxis is effective only during 
the incubation phase and should be administered as soon 
as possible. The prodromic phase is characterized by non 
specific symptoms that include fever, malaise, pharyngitis 
and paraesthesias at the site of  the bite.
During the encephalitic phase patients may present with 
fluctuating consciousness with intermittent episodes of  
confusion, hallucinations, agitation or aggressive behav-
ior6. Signs of  autonomic dysfunction are also observed, 
with hyper-salivation, dilated pupils, piloerection or pria-
pism. Hydrophobia (in 50% to 80% of  furious form) is 
a characteristic manifestation of  rabies and may be asso-
ciated with aerophobia which can be elicited by the ‘‘fan 
test’’. This is followed by paralysis and coma. Death is 
usually due to respiratory failure, which occurs  at a mean 
of  five days after onset of  symptoms, in the absence of  
intensive medical care.
Paralytic form closely mimics Guillain Barré syndrome 
and may not be recognized by physicians. Death is caused 
by respiratory failure and occurs in about 2 weeks.
Once rabies encephalitis develops, no therapy has proved 
effective. Recently some cases of  survivals have been 
reported7,8,9,10; but it is still unknown whether recovery 
resulted from therapy administrated to the patients or 
whether survival resulted from effective endogenous im-
mune response in combination with the massive critical 
care support implemented during hospitalization10.
Given the fatal outcome of  the disease, prevention 
should be implemented in endemic zones. It consists of  
vaccinating animals, providing post-exposure prophylaxis 
and especially spreading awareness among the targeted 
population.
In our case, although post exposure prophylaxis was es-
tablished in an optimal way, the wound was sutured which 
represents a second inoculation of  rabies virus and in-
creased the chances to develop lethal encephalitis.
Post-exposure prophylaxis (PEP) is not always effective. 
Treatment failure reported in the literature8-11 involved 
wounds in highly innerved regions in the body such as 
face wounds which is the case in this child (wound in 
lip and cheek), or errors in the management like: inap-
propriate wound cleaning, or the fact that the wound has 
been sutured before immunoglobulin injection, or may be 
some of  the wounds have been missed and not injected 
with immunoglobulin or immunoglobulin injection was 
administered too late (12 hours after the bite in this case). 
This case alerts the physician about the importance of  
the first aid of  the wound and of  not stitching the wound 
before immunoglobulin injection. The extensive wound 
washing which is not well known by physicians (immedi-
ate and thorough flushing and washing of  the wound for 
a minimum of  15 minutes with soap and water, detergent, 
povidone iodine or other substances that kill the rabies 
virus...) could have avoided the failure of  immunoglobu-
lin and vaccine and prevented rabies in this child6.
Physicians must be aware of  the clinical characteristics 
of  rabies and know how to prescribe vaccines and ERIG 
appropriately. Rabies encephalitis is a fatal disease and 
animal rabies control and surveillance are mandatory, 
especially in endemic areas. Our case has many learning 
points (clinical characteristic of  rabies and rabies post ex-
posure prophylaxis). It shows variability and non-specif-
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ic signs of  rabies encephalitis which are frequently not 
recognized by physicians (fever, non specific neurological 
signs, normal CT scan, CSF pleiocyosis), it also alerts the 
physicians in endemic areas to evoke human rabies when 
the patient presents with encephalitis signs even when 
he/she has received “adequate” PEP after a dog bite.
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